MusicRadar’s roundup spotlights five software synths that challenge traditional subtractive synthesis with methods ranging from additive resynthesis to organic growth models. The lineup includes ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...
Support for Xilinx's low-cost, high-volume Spartan-3A family of I/O-optimized FPGAs is now offered by Synplicity's Synplify Pro FPGA synthesis software. The Synplify Pro FPGA synthesis tool helps ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
Software features single-pass design flow and improved timing accuracy Synplify Premier synthesis software offers FPGA designers an integrated environment that features improved routing definition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results